People at higher risk of developing inherited cancers will be regularly checked and tracked under an NHS national genetics programme.

Opus Genetics, Inc., a clinical-stage biotechnology company focusing on gene therapies for inherited retinal diseases, announced upcoming presentations at various scientific conferences in May 2025.

A second pediatric patient was recently dosed, and the pediatric cohort is expected to complete enrollment in Q2 2025; initial data from all three patients anticipated in Q3 2025 FDA Type D meeting ...

Opus Genetics is conducting a trial for OPGx-MERTK gene therapy in Abu Dhabi, targeting MERTK-related retinitis pigmentosa using AAV-based delivery. The trial is a collaboration with Cleveland Clinic ...

FARMINGTON HILLS, Mich., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing gene therapies for the treatment of inherited ...

Opus Genetics is a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small molecule therapies for other ophthalmic disorders ...

NHS England » Thousands at risk of inherited cancers to receive regular NHS checks through world-first genetics programme ...

RESEARCH TRIANGLE PARK, N.C., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Opus Genetics (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal ...

When people ask "is cancer a genetic disease?" they are often thinking about family history: if my parent had cancer, will I? The short answer is complicated but important: cancer is driven by genetic ...

Discover interesting facts about how traits are passed down over generations through DNA. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. What ...

Parents’ genes – even when not directly inherited by a child – may play a role in their educational and mental health outcomes, finds a new report by UCL researchers. The report, Understanding the ...